Pharmaceuticals, GSK will invest in Siena

GlaxoSmithKline, the pharmaceuticals giant that generates approximately 1.5 billion Euros of turnover in Italy, lands in Tuscany, and promises to invest in Siena and the vaccines division.

Port of Livorno moves towards opening to private capital

The port of Livorno wagers on private investors for its relaunch. At the end of the summer, the Port of Livorno Authority, the public office that controls the Tuscan port, will begin its search for a stockholding partner by initiating a tender whose objective is ceding a considerable portion of the capital

Tuscan SME’s, the outlook for 2014 improves

Has the hour for the turning point come? The improved expectations for the 2014 turnover, the recovery of internal demand and the first prudent investment programs seem to provide an affirmative response